-
Vaccines, Blood & Biologics
-
Resources for You
-
-
Influenza A (H1N1) 2009 Monovalent
FDA approved these vaccines as a strain change to each manufacturer’s seasonal influenza vaccine. There is considerable experience with seasonal influenza vaccine development and production and influenza vaccines produced by this technology have a long and successful track record of safety and effectiveness in the United States. The Influenza A (H1N1) 2009 Monovalent vaccines will undergo the usual testing and lot release procedures that are in place for seasonal influenza vaccines.
-
Injectable Vaccines
-
-
Key Resources
- Influenza A (H1N1) 2009 Monovalent Vaccines Questions and Answers
- Use of Influenza A (H1N1) 2009 Monovalent Influenza Vaccine in Pregnant Women
- Influenza A (H1N1) 2009 Monovalent Vaccines Composition and Lot Release
H1N1 Flu vaccine availability and formulation. - Influenza A (H1N1) 2009 Monovalent Vaccines Descriptions and Ingredients
- Influenza A (H1N1) 2009 Monovalent Vaccine Safety Monitoring
- Draft Guidance for Industry: Recommendations for the Assessment of Blood Donor Suitability, Blood Product Safety, and Preservation of the Blood Supply in Response to Pandemic (H1N1) 2009 Virus (PDF - 80KB)
- Vaccines Approved for H1N1 Influenza Virus
FDA Consumer Update - FDA Expands Use of CSL Limited’s Seasonal and H1N1 Vaccines to Infants and Children
- Fraudulent H1N1 Products Widget
- Influenza Virus Vaccine Actions
- 2009 H1N1 (Swine) Flu Virus (Biologics)
H1N1 specific information for vaccines, blood and other areas of concern - FDA 2009 H1N1 (Swine) Flu Page
FDA is working to address human infection with the 2009 H1N1 flu virus as part of a team led by the Department of Health and Human Services.
-
-
Key Links
-
Contact Us
Consumer Affairs Branch (CBER)
- (800) 835-4709
- (301) 827-1800
- ocod@fda.hhs.gov
Division of Communication and Consumer Affairs
Office of Communication, Outreach and Development
Food and Drug Administration
1401 Rockville Pike
Suite 200N/HFM-47
Rockville, MD 20852-1448
-
-
-